Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Author:
Funder
Defense Threat Reduction Agency
National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference95 articles.
1. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies;Mitragotri;Nat. Rev. Drug Discov.,2014
2. Minimizing the immunogenicity of protein therapeutics;Chirino;Drug Discov. Today,2004
3. PEGylation, successful approach to drug delivery;Veronese;Drug Discov. Today,2005
4. A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs;Shankar;Nat. Biotechnol.,2007
5. Effect of pegylation on pharmaceuticals;Harris;Nat. Rev. Drug Discov.,2003
Cited by 494 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanoparticles in drinking water: Assessing health risks and regulatory challenges;Science of The Total Environment;2024-11
2. PEGylation-Dependent Cell Uptake of Lipid Nanoparticles Revealed by Spatiotemporal Correlation Spectroscopy;ACS Pharmacology & Translational Science;2024-09-05
3. Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions;Progress in Polymer Science;2024-09
4. Recent advances in zwitterionic polymers-based non-fouling coating strategies for biomedical applications;Materials Today Chemistry;2024-09
5. Golden Threads of Lipid Nanoparticles (LNPs) contributing to COVID-19 mRNA Vaccine: A Review;BioNanoScience;2024-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3